BIONET Corp.

TPEX:1784 Stock Report

Market Cap: NT$3.7b

BIONET Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Qing Yuan Kang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.6%
Management average tenureno data
Board average tenure18.9yrs

Recent management updates

Recent updates

Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

Apr 10
Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

Feb 10
If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

CEO

Qing Yuan Kang

no data

Tenure

Mr. Qing Yuan Kang is General Manager of BIONET Corp. Mr. Kang was Assistant to the President of BIONET Corp. Mr. Kang joined the BIONET Corp. on November 11, 2013.

Board Members

NamePositionTenureCompensationOwnership
Shao-Hua Huang
Independent Director18.5yrsno data0.025%
NT$ 952.8k
John Wagner
Member of Advisory Boardno datano datano data
Wen Yan
Independent Director18.9yrsno datano data
Zheng Huang
Director20.3yrsno data2.33%
NT$ 87.3m
Cheng-Hsian Coi
Director17.6yrsno data4.05%
NT$ 151.5m
Wen Zhang
Director22.1yrsno data1.9%
NT$ 70.9m
Cui Zhang
Supervisor24.8yrsno datano data
Zhao Fen Zhang
Supervisor17.6yrsno datano data
Han Zhang
Director18.9yrsno datano data
Shi Liang
Director11.2yrsno data0.51%
NT$ 18.9m
Cheng-Hsien Tsai
Chairman of the Boardno datano datano data
Han Tung Chang
Directorno datano datano data

18.9yrs

Average Tenure

56yo

Average Age

Experienced Board: 1784's board of directors are seasoned and experienced ( 18.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/10 20:08
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BIONET Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaowei HuangMasterlink Securities Corp.